0001104659-22-070661.txt : 20220613 0001104659-22-070661.hdr.sgml : 20220613 20220613201209 ACCESSION NUMBER: 0001104659-22-070661 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220610 FILED AS OF DATE: 20220613 DATE AS OF CHANGE: 20220613 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dukes Iain D. CENTRAL INDEX KEY: 0001681955 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40869 FILM NUMBER: 221013169 MAIL ADDRESS: STREET 1: 112 W. 34TH STREET, 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10120 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Theseus Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001745020 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 830712806 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 314 MAIN STREET, SUITE 04-200 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: (857) 400-9491 MAIL ADDRESS: STREET 1: 314 MAIN STREET, SUITE 04-200 CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 tm2218348-2_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-06-10 0 0001745020 Theseus Pharmaceuticals, Inc. THRX 0001681955 Dukes Iain D. C/O THESEUS PHARMACEUTICALS, INC. 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142 1 1 0 0 Chairman Stock Option (right to buy) 5.75 2022-06-10 4 A 0 30000 0 A 2032-06-09 Common Stock 30000 30000 D Stock Option (right to buy) 5.75 2022-06-10 4 A 0 15000 0 A 2032-06-09 Common Stock 15000 15000 D The options are subject to a service-based vesting requirement, which shall be satisfied on the earlier of (i) June 10, 2023 or (ii) the day prior to the date of the issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service with the issuer on such vesting date. The options are subject to a service-based vesting requirement, which shall be satisfied over a four-year period with respect to 1/48th of the shares vesting monthly after June 10, 2022, subject to the Reporting Person's continuous service with the issuer on each such vesting date. /s/ Bradford Dahms - Attorney-in-Fact 2022-06-13